Exercise-induced upregulation of TRIM9 attenuates neuroinflammation in Alzheimer’s disease-like rat DOI
Xinyang Zhang, Jiahao Zhang, Xiaochuan Li

et al.

International Immunopharmacology, Journal Year: 2024, Volume and Issue: 144, P. 113676 - 113676

Published: Nov. 23, 2024

Language: Английский

Recent advances in Alzheimer’s disease: Mechanisms, clinical trials and new drug development strategies DOI Creative Commons
Jifa Zhang, Yinglu Zhang, Jiaxing Wang

et al.

Signal Transduction and Targeted Therapy, Journal Year: 2024, Volume and Issue: 9(1)

Published: Aug. 23, 2024

Abstract Alzheimer’s disease (AD) stands as the predominant form of dementia, presenting significant and escalating global challenges. Its etiology is intricate diverse, stemming from a combination factors such aging, genetics, environment. Our current understanding AD pathologies involves various hypotheses, cholinergic, amyloid, tau protein, inflammatory, oxidative stress, metal ion, glutamate excitotoxicity, microbiota-gut-brain axis, abnormal autophagy. Nonetheless, unraveling interplay among these pathological aspects pinpointing primary initiators require further elucidation validation. In past decades, most clinical drugs have been discontinued due to limited effectiveness or adverse effects. Presently, available primarily offer symptomatic relief often accompanied by undesirable side However, recent approvals aducanumab ( 1 ) lecanemab 2 Food Drug Administration (FDA) present potential in disrease-modifying Nevertheless, long-term efficacy safety need Consequently, quest for safer more effective persists formidable pressing task. This review discusses pathogenesis, advances diagnostic biomarkers, latest updates trials, emerging technologies drug development. We highlight progress discovery selective inhibitors, dual-target allosteric modulators, covalent proteolysis-targeting chimeras (PROTACs), protein-protein interaction (PPI) modulators. goal provide insights into prospective development application novel drugs.

Language: Английский

Citations

135

Farrerol alleviates cognitive impairments in chronic cerebral hypoperfusion via suppressing NLRP3 inflammasome-mediated pyroptosis DOI
Jie Zhang, Yaxuan Zhang, Yueqi Zhang

et al.

International Immunopharmacology, Journal Year: 2025, Volume and Issue: 153, P. 114442 - 114442

Published: March 19, 2025

Language: Английский

Citations

1

Neuroinflammation and Neurodegenerative Diseases: How Much Do We Still Not Know? DOI Creative Commons
Carmela Rita Balistreri, Roberto Monastero

Brain Sciences, Journal Year: 2023, Volume and Issue: 14(1), P. 19 - 19

Published: Dec. 23, 2023

The term “neuroinflammation” defines the typical inflammatory response of brain closely related to onset many neurodegenerative diseases (NDs). Neuroinflammation is well known, but its mechanisms and pathways are not entirely comprehended. Some progresses have been achieved through efforts research. Consequently, new cellular molecular mechanisms, diverse conventional, emerging. In listing some those that will be subject our description discussion, essential important roles peripheral infiltrated monocytes clonotypic cells, alterations in gut–brain axis, dysregulation apelinergic system, endothelial glycocalyx component neuronal vascular units, variations expression genes levels encoding molecules by action microRNAs (miRNAs), or other epigenetic factors distinctive transcriptional factors, as role autophagy, ferroptosis, sex differences, modifications circadian cycle. Such can add significantly understanding complex etiological puzzle neuroinflammation ND. addition, they could represent biomarkers targets ND, which increasing elderly.

Language: Английский

Citations

20

Targeting STAT3 signaling pathway in the treatment of Alzheimer’s disease with compounds from natural products DOI

Xiyue Wen,

Jinyue Hu

International Immunopharmacology, Journal Year: 2024, Volume and Issue: 141, P. 112936 - 112936

Published: Aug. 19, 2024

Language: Английский

Citations

4

Spatiotemporal Dysregulation of Neuron–Glia Related Genes and Pro-/Anti-Inflammatory miRNAs in the 5xFAD Mouse Model of Alzheimer’s Disease DOI Open Access
M. Di Ianni, Miriam Corraliza-Gómez, Tiago Costa-Coelho

et al.

International Journal of Molecular Sciences, Journal Year: 2024, Volume and Issue: 25(17), P. 9475 - 9475

Published: Aug. 31, 2024

Alzheimer's disease (AD), the leading cause of dementia, is a multifactorial influenced by aging, genetics, and environmental factors. miRNAs are crucial regulators gene expression play significant roles in AD onset progression. This exploratory study analyzed levels 28 genes 5 (miR-124-3p, miR-125b-5p, miR-21-5p, miR-146a-5p, miR-155-5p) related to pathology neuroimmune responses using RT-qPCR. Analyses were conducted prefrontal cortex (PFC) hippocampus (HPC)

Language: Английский

Citations

4

Developing Non-Invasive Molecular Markers for Early Risk Assessment of Alzheimer's Disease DOI Creative Commons

Tapas Kumar Sur,

Tanmoy Mondal, Zarish Noreen

et al.

Biomarkers in Neuropsychiatry, Journal Year: 2025, Volume and Issue: unknown, P. 100120 - 100120

Published: Jan. 1, 2025

Language: Английский

Citations

0

Neurodegenerative diseases and neuroinflammation-induced apoptosis DOI Creative Commons

Shi Huang,

Yaxin Lu,

Wenjun Fang

et al.

Open Life Sciences, Journal Year: 2025, Volume and Issue: 20(1)

Published: Jan. 1, 2025

Abstract Neuroinflammation represents a critical pathway in the brain for clearance of foreign bodies and maintenance homeostasis. When neuroinflammatory process is dysregulate, such as over-activation microglia, which results excessive accumulation free oxygen inflammatory factors brain, among other factors, it can lead to an imbalance homeostasis development various diseases. Recent research has indicated that numerous neurodegenerative diseases closely associated with neuroinflammation. The pathogenesis neuroinflammation intricate, involving alterations genes proteins, well activation inhibition signaling pathways. Furthermore, inflammation result neuronal cell apoptosis, further exacerbate extent disease. This article presents summary recent studies on relationship between apoptosis caused by aim identify link two provide new ideas targets exploring pathogenesis, prevention treatment

Language: Английский

Citations

0

The effect of tanshinones on cognitive impairments in animal models of Alzheimer’s disease: a systematic review and meta-analysis DOI Creative Commons
Shuwei Wang, Jin‐Hao Yang, Wenbin Zheng

et al.

Frontiers in Pharmacology, Journal Year: 2025, Volume and Issue: 16

Published: Feb. 27, 2025

Alzheimer's disease (AD) is an age-related neurological illness that poses a significant hazard to human health. A fat-soluble compound called tanshinones was isolated from Danshen, traditional Chinese herb. Recent years have seen reports of clinical trials examining the effects on cognitive impairment among individuals with AD, as well publication pertinent basic research. Tanshinones are not yet commonly utilized in therapeutic treatment and effectiveness program for AD adequately supported by evidence. To assess impact experimental rodent models we carried out systematic review this work. All relevant studies usage model animals published PubMed, Cochrane Library, Web Science, EMBASE, Biomedicine Database, China National Knowledge Infrastructure before 8 September 2024, were systematically retrieved. methodological quality, CAMARADES checklist used. Meta-analysis calculated graphed Stata 14.0 software. For each outcome every study, standard mean difference (SMD) 95% confidence interval (CI) effect size calculated. Fourteen included study. Compared group without intervention, significantly reduced number escape latency [SMD = -2.082, CI (-2.481, -1.683), p < 0.001]. also increased times platform crossing 1.464, (1.183, 1.744), 0.001] time target quadrants 2.703, (2.132, 3.275), thought positive according findings However, level quality research may accuracy outcomes. Thus, more high-quality randomized controlled animal required guide future scientific identifier CRD42024557980.

Language: Английский

Citations

0

Enhanced neuroprotection against Alzheimer’s disease by combining <i>Inula viscosa</i> with curcumin: an <i>in vitro</i> study DOI Creative Commons
Arash Alizadeh Yegani, Gülüzar Özbolat, Seydi Ahmet Şengül

et al.

Archives of Medical Science, Journal Year: 2025, Volume and Issue: unknown

Published: March 21, 2025

Introduction Alzheimer’s disease (AD), the most prevalent type of dementia among older individuals, is characterized by severe neurodegeneration with symptoms progressive loss cognitive capacity. We aimed to investigate effects curcumin (Curc) and Inula viscosa (IV) plant extracts on apoptosis oxidative stress in an amyloid-β (Aβ<i></i>)-induced vitro AD model. Material methods The human glioblastoma cell line (U87) was treated Aβ produce Treatment groups were: + Curc, IV, IV Curc. Cell viability assay performed analyze cytotoxicity. Caspase-3 (CASP3) levels were measured evaluate apoptosis. For stress, glutathione peroxidase (GPx), catalase (CAT), superoxide dismutase (SOD), total antioxidant (TAS), oxidant (TOS) analyzed spectrophotometrically. Results Combinatory application Curc post-Aβ treatment increased U87 cells. Aβ-upregulated CASP3 markedly reduced upon co-treatment. Anti-oxidant parameters, i.e., SOD, CAT, GPx, TAS levels, significantly elevated Curc-treated group compared group. TOS level after exposure returned its basal Conclusions co-treatment apoptosis-related supported activity Aβ-induced model can be a promising therapeutic strategy against AD.

Language: Английский

Citations

0

Multi-target approach to Alzheimer’s disease prevention and treatment: antioxidant, anti-inflammatory, and amyloid- modulating mechanisms DOI
Kashif Abbas, Mohd Rais Mustafa, Mudassir Alam

et al.

Neurogenetics, Journal Year: 2025, Volume and Issue: 26(1)

Published: April 1, 2025

Language: Английский

Citations

0